Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02522871 · ClinicalTrials.gov registry record · NA
OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation
A NA study, sponsored by TransMedics.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT02522871 is a NA study that has completed, run by TransMedics. The registered enrollment target is 300 participants.
The verdict
NCT02522871, a NA study, has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
A prospective, phased-pivotal, international randomized trial to evaluate the effectiveness of the OCS™ Liver to preserve and assess donor livers intended for transplantation.
Interventions
- OTHER Control
- DEVICE OCS™ Liver System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-01-24 |
| Est. Completion | 2021-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02522871
The ClinicalTrials.gov registry entry for NCT02522871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02522871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02522871 about?
NCT02522871 is a clinical study titled "OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation". A prospective, phased-pivotal, international randomized trial to evaluate the effectiveness of the OCS™ Liver to preserve and assess donor livers intended for transplantation.
What is the current status of trial NCT02522871?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-01-24. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT02522871?
The interventions under investigation include: Control (OTHER), OCS™ Liver System (DEVICE).
Who is sponsoring clinical trial NCT02522871?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.